title: Comparison of 200 mg cimetidine with multiple doses of antacid on extent and duration of rise in gastric pH in volunteers.
abstract: The effects on gastric pH of a single administration of 200 mg cimetidine (Tagamet HB) were compared to multiple doses of a liquid antacid (Mylanta) using a pH microelectrode. Gastric pH was monitored for 8 hr in 20 normal fasting volunteers in a crossover design to compare Tagamet HB (two 100-mg tablets administered as a single dose) with Mylanta Suspension, an initial 17.5-ml dose of antacid with additional doses given when gastric pH fell below 3.5. Both treatments increased the pH above 3.5 during the first hour following treatment, with Mylanta being more effective than Tagamet HB. Interestingly, to sustain the reduction in acidity during this 1-hr interval, a mean of 2.45 doses of antacid were administered. Although multiple doses of Mylanta kept the pH above 3.5 (for at least 25% of the time) for the first 4 hr, the single administration of 200 mg of Tagamet HB maintained gastric pH above 3.5 (greater than 25% of time) for the full 8 hr of the study. Compared to Mylanta, the percent of time gastric pH was >3.5 was significantly higher with Tagamet HB during the 3rd to 8th hour after dosing. This study demonstrates that 200 mg of cimetidine administered as Tagamet HB is significantly more effective and has a much longer duration of action in raising gastric pH >3.5 than six doses of Mylanta.
authors.affiliation: Nutrition & Metabolism Research Group, University of Alberta, Edmonton, Canada.
authors.forename: A B
authors.initials: AB
authors.lastname: Thomson
authors.forename: P
authors.initials: P
authors.lastname: Kirdeikis
authors.forename: L
authors.initials: L
authors.lastname: Zuk
mesh_terms: D000328:Adult; D000536:Aluminum Hydroxide / Q000008:administration & dosage* / Q000494:pharmacology; D000863:Antacids / Q000008:administration & dosage* / Q000494:pharmacology; D002927:Cimetidine / Q000008:administration & dosage* / Q000494:pharmacology; D018592:Cross-Over Studies; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D005260:Female; D005744:Gastric Acid / Q000378:metabolism*; D005745:Gastric Acidity Determination; D006635:Histamine H2 Antagonists / Q000008:administration & dosage* / Q000494:pharmacology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008276:Magnesium Hydroxide / Q000008:administration & dosage* / Q000494:pharmacology; D008297:Male; D012841:Simethicone / Q000008:administration & dosage* / Q000494:pharmacology; D013997:Time Factors
chemical_list: D000863:Antacids; D004338:Drug Combinations; D006635:Histamine H2 Antagonists; C008570:aluminum hydroxide, magnesium hydroxide, simethicone drug combination; D000536:Aluminum Hydroxide; D002927:Cimetidine; D012841:Simethicone; D008276:Magnesium Hydroxide